At least in a mammary tumor model, this has been directly linked to the ability of IL-10 to suppress IL-12 production by cDC1s, reducing the percentage of CD8+ T cells that display a cytotoxic effector phenotype (45). This evidence concerns the gene CD8A and breast cancer.